Search Results - "Angel, Alon"

Observational cohort study of IP-10's potential as a biomarker to aid in inflammation regulation within a clinical decision support protocol for patients with severe COVID-19 by Lev, Shaul, Gottesman, Tamar, Sahaf Levin, Gal, Lederfein, Doron, Berkov, Evgeny, Diker, Dror, Zaidman, Aliza, Nutman, Amir, Ilan Ber, Tahel, Angel, Alon, Kellerman, Lior, Barash, Eran, Navon, Roy, Boico, Olga, Israeli, Yael, Rosenberg, Michal, Gelman, Amir, Kalfon, Roy, Simon, Einav, Avni, Noa, Hainrichson, Mary, Zarchin, Oren, Gottlieb, Tanya M, Oved, Kfir, Eden, Eran, Tadmor, Boaz

“…Treatment of severely ill COVID-19 patients requires simultaneous management of oxygenation and inflammation without compromising viral clearance. While…”
Get full text

An immune-protein score combining TRAIL, IP-10 and CRP for predicting severe COVID-19 disease by Mastboim, Niv Samuel, Angel, Alon, Shaham, Oded, Ber, Tahel Ilan, Navon, Roy, Simon, Einav, Rosenberg, Michal, Israeli, Yael, Hainrichson, Mary, Avni, Noa, Reiner, Eran, Feigin, Paul, Oved, Kfir, Tadmor, Boaz, Singer, Pierre, Kagan, Ilya, Lev, Shaul, Diker, Dror, Jarjou'I, Amir, Kurd, Ramzi, Ben-Chetrit, Eli, Danziger, Guy, Tegethoff, Sina A., Papan, Cihan, Motov, Sergey, Shapira, Ma'anit, Stein, Michal, Gottlieb, Tanya M., Eden, Eran, Klein, Adi

“…•The levels of TRAIL, IP-10, and CRP are integrated into a single numeric score.•This host score is an early indicator of severe outcome for COVID-19…”
Get full text

ON THE EQUATOR by Merin, Roei, Freund, Yaacov, Angel, Alon, Stashefsky Margalit, Ruth, Shavit, Itai, Neuberger, Ami, Epstein, Danny

“…Elective clerkships in low income countries have been an integral part of the curriculum in the majority of medical schools worldwide. These programs expose…”
Get more information

Interferon gamma-induced protein 10 (IP-10) for the early prognosis of the risk for severe respiratory failure and death in COVID-19 pneumonia by Samaras, Charilaos, Kyriazopoulou, Evdoxia, Poulakou, Garyfallia, Reiner, Eran, Kosmidou, Maria, Karanika, Ioanna, Petrakis, Vasileios, Adamis, George, Gatselis, Nikolaos K., Fragkou, Archontoula, Rapti, Aggeliki, Taddei, Eleonora, Kalomenidis, Ioannis, Chrysos, George, Bertoli, Giulia, Kainis, Ilias, Alexiou, Zoi, Castelli, Francesco, Saverio Serino, Francesco, Bakakos, Petros, Nicastri, Emanuele, Tzavara, Vassiliki, Kostis, Evangelos, Dagna, Lorenzo, Koukidou, Sofia, Tzatzagou, Glykeria, Chini, Maria, Bassetti, Matteo, Trakatelli, Christina, Tsoukalas, George, Selmi, Carlo, Samarkos, Michael, Pyrpasopoulou, Athina, Masgala, Aikaterini, Antonakis, Emmanouil, Argyraki, Aikaterini, Akinosoglou, Karolina, Sympardi, Styliani, Panagopoulos, Periklis, Milionis, Haralampos, Metallidis, Simeon, Syrigos, Konstantinos N., Angel, Alon, Dalekos, George N., Netea, Mihai G., Giamarellos-Bourboulis, Evangelos J.

“…•CRP, IP-10 and TRAIL were compared to suPAR for predicting outcome in COVID-19.•IP-10 ≥ 2000 pg/ml predicts equally well to suPAR (sensitivity…”
Get full text

426. Use of Real Time IP-10 Measurements to Identify and Monitor the Dysregulated Immune Response in COVID-19 Patients by Lev, Shaul, Gottesman, Tamar, Levin, Gal Shachaf, Ber, Tahel Ilan, Angel, Alon, Kellerman, Lior, Barash, Eran, Navon, Roy, Simon, Einav, Avni, Noa, Hainrichson, Mary, Gottlieb, Tanya, Oved, Kfir, Eden, Eran, Tadmor, Boaz

“…Abstract Background It is estimated that up to 10% of SARS-CoV-2 patients progress from early and pulmonary stages to the most severe stage of illness, which…”
Get full text

32. Host Immune-Protein Signature Combining TRAIL, IP-10 and CRP for Early and Accurate Prediction of Severe COVID-19 Outcome by Angel, Alon, Mastboim, Niv Samuel, Shaham, Oded, Ber, Tahel Ilan, Navon, Roy, Simon, Einav, Rosenberg, Michal, Israeli, Yael, Hainrichson, Mary, Avni, Noa, Reiner, Eran, Feigin, Paul, Oved, Kfir, Tadmor, Boaz, Singer, Pierre, Kagan, Ilya, Lev, Shaul, Diker, Dror, Jarjou’i, Amir, Kurd, Ramzi, Ben-Chetrit, Eli, Danziger, Guy, Papan, Cihan, Motov, Sergey, Shapira, Maanit, Stein, Michal, Klein, Adi, Gottlieb, Tanya, Eden, Eran

“…Abstract Background Accurately identifying COVID-19 patients at-risk to deteriorate remains challenging. Dysregulated immune responses impact disease…”
Get full text